Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Letterio

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Research|June 1, 1995
Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell linesP S Cohen, J J Letterio, C Gaetano, et al.
The EMBO Journal|March 4, 1999
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaX Yang, J J Letterio, R J Lechleider, et al.
The Journal of Experimental Medicine|May 1, 1996
Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouseY Vodovotz, A G Geiser, L Chesler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout miceT Nakabayashi, J J Letterio, A G Geiser, et al.
Nature Medicine|July 14, 1998
Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiencyB Tang, E P Böttinger, S B Jakowlew, et al.
Inflammation|April 26, 2001
TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissuesT Nakabayashi, K M Sakata, A Sakata, et al.
The Journal of Clinical Investigation|August 1, 1997
A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null miceT A Borkowski, J J Letterio, C L Mackall, et al.
The Journal of Clinical Investigation|November 1, 1996
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expressionJ J Letterio, A G Geiser, A B Kulkarni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouseS Kobayashi, K Yoshida, J M Ward, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Research|June 1, 1995
Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell linesP S Cohen, J J Letterio, C Gaetano, et al.
The EMBO Journal|March 4, 1999
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaX Yang, J J Letterio, R J Lechleider, et al.
The Journal of Experimental Medicine|May 1, 1996
Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouseY Vodovotz, A G Geiser, L Chesler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout miceT Nakabayashi, J J Letterio, A G Geiser, et al.
Nature Medicine|July 14, 1998
Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiencyB Tang, E P Böttinger, S B Jakowlew, et al.
Inflammation|April 26, 2001
TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissuesT Nakabayashi, K M Sakata, A Sakata, et al.
The Journal of Clinical Investigation|August 1, 1997
A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null miceT A Borkowski, J J Letterio, C L Mackall, et al.
The Journal of Clinical Investigation|November 1, 1996
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expressionJ J Letterio, A G Geiser, A B Kulkarni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouseS Kobayashi, K Yoshida, J M Ward, et al.
Pageof 4